US FDA's FY 11 funding proposals are inadequate, says advocacy group
This article was originally published in SRA
Executive Summary
The US Senate Appropriations Committee, in its mark-up of the Food and Drug Administration funding bill for fiscal year 2011, has proposed about $2.5 billion for the agency – a $159 million increase above the FY 10 enacted level and the same amount as the president's request1,2.